Subject(s)
Eosinophilia , Inferior Wall Myocardial Infarction , Myocarditis , Humans , Male , Acute Disease , Biopsy , Diagnosis, Differential , Electrocardiography , Eosinophilia/diagnosis , Hypereosinophilic Syndrome/diagnosis , Hypereosinophilic Syndrome/complications , Inferior Wall Myocardial Infarction/diagnosis , Inferior Wall Myocardial Infarction/etiology , Myocarditis/diagnosis , Predictive Value of Tests , AdultABSTRACT
Here, we report a case of ventricular septal perforation complicated with right ventricular infarction after inferior acute myocardial infarction, which was associated with a poor clinical outcome despite the successful surgical treatment.
Subject(s)
May-Thurner Syndrome , Pulmonary Embolism , Venous Thrombosis , Humans , May-Thurner Syndrome/complications , May-Thurner Syndrome/diagnosis , Pulmonary Embolism/diagnosis , Pulmonary Embolism/diagnostic imaging , Venous Thrombosis/diagnosis , Venous Thrombosis/diagnostic imaging , Cerebral Infarction/complicationsABSTRACT
The global coronavirus disease-2019 (COVID-19) pandemic is associated with reduced rate of percutaneous coronary intervention (PCI). However, there were a few data showing how emergency medical system (EMS) and management strategies for acute coronary syndrome (ACS) changed during the pandemic. We sought to clarify changes on characteristics, treatments, and in-hospital mortality of patients with ACS transported via EMS between pre- and post-pandemic. We examined consecutive 656 patients with ACS admitted to Sapporo City ACS Network Hospitals between June 2018 and November 2021. The patients were divided into pre- and post-pandemic groups. The number of ACS hospitalizations declined significantly during the pandemic (proportional reduction 66%, coefficient -0.34, 95% CI -0.50 to -0.18, p < 0.001). The median time from an EMS call to hospital was significantly longer in post-pandemic group than in pre-pandemic group (32 [26-39] vs. 29 [25-36] min, p = 0.008). There were no significant differences in the proportion of patients with ACS receiving PCI, and in-hospital mortality between the groups. The COVID-19 pandemic had a significant impact on EMS and management in patients with ACS. Although a significant decline was observed in ACS hospitalizations, the proportion of patients with ACS receiving emergency PCI remained during the pandemic.
Subject(s)
Acute Coronary Syndrome , COVID-19 , Percutaneous Coronary Intervention , Humans , Acute Coronary Syndrome/epidemiology , Acute Coronary Syndrome/therapy , COVID-19/epidemiology , COVID-19/therapy , Pandemics , Hospitalization , Treatment OutcomeSubject(s)
Cardiac Resynchronization Therapy , Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography , Myocardial Perfusion Imaging , Ventricular Dysfunction, Left , Humans , Tomography, Emission-Computed, Single-Photon/methods , Perfusion , Myocardial Perfusion Imaging/methods , Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography/methodsSubject(s)
Coronary Stenosis/diagnostic imaging , Coronary Stenosis/physiopathology , Coronary Angiography , Coronary Stenosis/etiology , Dipyridamole , Echocardiography , Electrocardiography , Exercise Test , Humans , Male , Middle Aged , Myocardial Perfusion Imaging , Organophosphorus Compounds , Organotechnetium Compounds , Tomography, Emission-Computed, Single-Photon , Vasodilator AgentsABSTRACT
tert-Butyl esters are demonstrated to function as chain transfer agents (CTAs) in the cationic copolymerization of vinyl ether (VE) and oxirane via concurrent vinyl-addition and ring-opening mechanisms. In the copolymerization of isopropyl VE and isobutylene oxide (IBO), the IBO-derived propagating species reacts with tert-butyl acetate to generate a copolymer chain with an acetoxy group at the ω-end. This reaction liberates a tert-butyl cation; hence, a polymer chain with a tert-butyl group at the α-end is subsequently generated. Other tert-butyl esters also function as CTAs, and the substituent attached to the carbonyl group affects the chain transfer efficiency. In addition, ethyl acetate does not function as a CTA, which suggests the importance of the liberation of a tert-butyl cation for the chain transfer process. Chain transfer reactions by tert-butyl esters potentially occur reversibly through the reaction of the propagating cation with the ester group at the ω-end of another chain.
Subject(s)
Epoxy Compounds , Esters , Cations , Ethers , Vinyl CompoundsABSTRACT
Paroxysmal atrial fibrillation (PAF) reduces atrial contractility due to atrial remodeling, but little is known about the process by which contractile function is reconstituted after spontaneous conversion to sinus rhythm (SR). A 63-year-old healthy man developed PAF. PAF persisted for 2 days before spontaneous conversion to SR. Serial echocardiograms were performed at 1, 24 h, 3/4/7 days after conversion. Longitudinal myocardial strain during the pump phase of the left atrium (LA) was generally reduced at 1 h. Normal strain of the LA was restored at 3 days with the exception of the lateral wall, where restoration was delayed until 4 days. The ratio between the mitral early and atrial diastolic velocities (E/A) at 24 h was within a pseudonormal range at 1.8, but the ratio between E and early mitral annulus velocity (e': E/e') remained normal. The E/A ratio gradually decreased until 7 days post conversion, but the E/e' ratio remained normal throughout the observation period.
Subject(s)
Heart Failure , Heart Neoplasms , Myxoma , Takotsubo Cardiomyopathy , Heart Atria/diagnostic imaging , Heart Failure/diagnosis , Heart Failure/etiology , Heart Neoplasms/complications , Heart Neoplasms/diagnosis , Heart Neoplasms/surgery , Humans , Myxoma/complications , Myxoma/diagnosis , Myxoma/surgery , Takotsubo Cardiomyopathy/complications , Takotsubo Cardiomyopathy/diagnosisSubject(s)
Coronary Thrombosis/etiology , Coronary Vessels/pathology , Drug-Eluting Stents , Percutaneous Coronary Intervention/instrumentation , Prosthesis Failure , Aged , Coronary Thrombosis/diagnostic imaging , Coronary Thrombosis/pathology , Coronary Thrombosis/therapy , Coronary Vessels/diagnostic imaging , Drug Administration Schedule , Female , Humans , Percutaneous Coronary Intervention/adverse effects , Platelet Aggregation Inhibitors/administration & dosage , Risk Factors , ST Elevation Myocardial Infarction/etiology , Thrombectomy , Time Factors , Treatment OutcomeABSTRACT
BACKGROUND: The relationship between eicosapentaenoic acid (EPA) therapy and coronary plaque stability assessed by optical frequency domain imaging (OFDI) has not been thoroughly described. HYPOTHESIS: EPA therapy is associated with decreased plaque instability in patients undergoing percutaneous coronary intervention (PCI) using OFDI. METHODS: Data on coronary artery plaques from 121 patients who consecutively underwent PCI between October 2015 and July 2018 were retrospectively analyzed. Of these patients, 109 were untreated (no-EPA group), whereas 12 were treated with EPA (EPA group). Each plaque's morphological characteristics were analyzed using OFDI. RESULTS: We used 1:4 propensity score matching for patients who received or did not receive EPA therapy before PCI. Baseline characteristics were balanced between both groups (age, sex, body mass index, diabetes mellitus, hypertension, dyslipidemia, chronic kidney disease, smoking, previous PCI or coronary artery bypass grafting, previous myocardial infarction, prior statin use, acute coronary syndrome, hemoglobin A1c level, low-density lipoprotein cholesterol concentration, triglyceride concentration, and high-density lipoprotein cholesterol concentration). OFDI data from 60 patients were analyzed in this study. The EPA group had significantly lower mean lipid index (818 ± 806 vs 1574 ± 891) and macrophage grade (13.5 ± 5.9 vs 19.3 ± 7.4) but higher mean minimum fibrous cap thickness (109.2 ± 55.7 vs 81.6 ± 36.4 µm) than the no-EPA group (P = 0.010, 0.019, and 0.040, respectively). Multiple logistic regression analyses showed that prior EPA use was independently associated with lower lipid index and macrophage grade (P = 0.043 and 0.024, respectively). CONCLUSION: This OFDI analysis suggests that EPA therapy is associated with decreased plaque instability in patients undergoing PCI.
Subject(s)
Coronary Artery Disease/therapy , Coronary Vessels/diagnostic imaging , Eicosapentaenoic Acid/therapeutic use , Plaque, Atherosclerotic/therapy , Tomography, Optical Coherence/methods , Aged , Biomarkers/blood , Coronary Angiography , Coronary Artery Disease/blood , Coronary Artery Disease/diagnosis , Female , Follow-Up Studies , Humans , Lipids/blood , Male , Percutaneous Coronary Intervention/methods , Plaque, Atherosclerotic/blood , Plaque, Atherosclerotic/diagnosis , Reproducibility of Results , Retrospective Studies , Treatment OutcomeABSTRACT
Obstructive sleep apnea (OSA) is associated with coronary artery disease (CAD) and with an increased risk for myocardial infarction, stroke or death due to cardiovascular disease. Optical frequency-domain imaging (OFDI) is a useful modality for evaluating the characteristics of atherosclerotic plaque. The purpose of the study was to use OFDI to investigate the association of OSA with coronary plaque characteristics in patients undergoing percutaneous coronary intervention (PCI). We retrospectively analyzed OFDI data for coronary artery plaques from 15 patients with OSA and 35 non-OSA patients treated between October 2015 and October 2018. Plaque morphology was evaluated for 70 lesions, including 21 from patients with OSA and 49 from non-OSA patients. Compared with the non-OSA group, patients with OSA had significantly higher prevalences of thinned cap fibroatheroma (TCFA) (67% vs. 35%, P = 0.014) and microchannels (86% vs. 55%, P = 0.014); a significantly higher mean lipid index (1392 ± 982 vs. 817 ± 699, P = 0.021), macrophage grade (8.4 ± 6.4 vs. 4.8 ± 4.5, P = 0.030), and maximum number of microchannels (1.5 ± 1.0 vs. 0.7 ± 0.7, P = 0.001); and a significantly lower mean minimum fibrous cap thickness (69.4 ± 28.7 vs. 96.1 ± 51.8 µm, P = 0.008). This OFDI analysis suggests that OSA is associated with unstable plaque characteristics in patients with CAD. More intensive medical management for stabilization of coronary atherosclerotic plaque is required in patients with OSA.
Subject(s)
Coronary Artery Disease/etiology , Percutaneous Coronary Intervention , Plaque, Atherosclerotic/complications , Sleep Apnea, Obstructive/complications , Aged , Aged, 80 and over , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/pathology , Female , Humans , Logistic Models , Male , Middle Aged , Plaque, Atherosclerotic/diagnostic imaging , Plaque, Atherosclerotic/pathology , Polysomnography , Retrospective Studies , Sleep Apnea, Obstructive/pathology , Tomography, Optical CoherenceABSTRACT
BACKGROUND: The optimal implantation site of a new implantable cardiac monitor (ICM) named Reveal LINQ® may be limited based on a sufficient amplitude of R wave potential (AEP) acquisition because it is the same anatomic area used for transthoracic echocardiography (TTE). METHODS: Among 18 healthy volunteers, we assessed AEPs in 3 combinations through parasternal placement of 2 electrodes, (i) in the 4th intercostal space (ICS; site A/setting a; A/a), (ii) the same setting in the 5th ICS (site B/setting a; B/a), and (iii) in a sagittal plane relative to the left sternal border at the 4th ICS (site A/setting b; A/b), and further measured AFPs in several body positions in all site-setting combinations: supine, left and right lateral decubitus, sitting, and standing. The degree of interference with TTE performance was assessed by placement of an imitation ICM in setting a at both sites A and B. RESULTS: Only the AEPs in A/a and B/a met the criteria (AEP ≥ 0.3 mV) in all positions. The AEPs in the supine position with all combinations were higher than those achieved in other positions (P < .001). The imitation interfered with TTE performance at site A among 78% of subjects, but only 17% at site B (P = .0006). The end-diastolic dimension of the left ventricle at site A was decreased after the imitation placement (P = .028). At site B, all female subjects complained of discomfort because their brassieres overlaid the imitation. CONCLUSION: The B/a combination is optimal; however, the personal discomfort related to brassieres should be considered.
ABSTRACT
BACKGROUND: A high coronary artery calcium score (CACS) predicts a poor prognosis in patients with coronary artery disease. We examined the relationship between the bifurcation angle and the CACS of the left main (LM) and left anterior descending (LAD) arteries in patients suffering from chronic kidney disease (CKD). METHODS: We analyzed the data of 121 patients who underwent coronary computed tomography between October 2014 and June 2015 and whose estimated glomerular filtration rate (eGFR) was <60 ml/min/1.73 m2. The LM-LAD bifurcation angle was measured by 3-dimensional coronary computed tomography. The CACS of the LM-LAD arteries was also calculated. We excluded stent recipients and patient who had undergone coronary artery bypass graft surgery. RESULTS: In the overall sample, the mean ± standard deviation (range) LM-LAD bifurcation angle was 35.9 ± 11.4° (6.8-79.4°) and mean CACS was 227 ± 351 (0 to 1,695). The mean LM-LAD arteries angle was 40.3° ± 10.0° in 39 patients whose CACS was ≥200, versus 33.8° ± 11.6° in 82 patients with CACS <200 (p = 0.003). A weak, but positive correlation (r = 0.269, p = 0.003) was observed between the LM-LAD arteries angle and CACS of the LM-LAD arteries. By multiple variable analysis, hemoglobin A1c, triglycerides, eGFR and the LM-LAD arteries angle were independent predictors of a high CACS of the LM-LAD arteries. CONCLUSION: In patients with CKD, a wide LM-LAD arteries angle was associated with a high CACS of the LM-LAD arteries. The prognostic value of this observation warrants further evaluation.